JHS Svendgaard Laboratories Limited

NSE JHS.NS

JHS Svendgaard Laboratories Limited EBT Margin for the year ending March 31, 2024: -4.91%

JHS Svendgaard Laboratories Limited EBT Margin is -4.91% for the year ending March 31, 2024, a 78.36% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

JHS Svendgaard Laboratories Limited EBT Margin for the year ending March 31, 2023 was -22.70%, a -18,942.41% change year over year.
JHS Svendgaard Laboratories Limited EBT Margin for the year ending March 31, 2022 was 0.12%, a -87.54% change year over year.
JHS Svendgaard Laboratories Limited EBT Margin for the year ending March 31, 2021 was 0.97%, a 122.92% change year over year.
JHS Svendgaard Laboratories Limited EBT Margin for the year ending March 31, 2020 was -4.22%, a -154.30% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

NSE: JHS.NS

JHS Svendgaard Laboratories Limited

CEO	Mr. Paramvir Singh Pabla
IPO Date	Oct. 23, 2006
Location	India
Headquarters	B-1/E-23, Mohan Co-operative Indu. Area
Employees	250
Sector	Consumers Staples
Industries Personal Care Cleaning Supplies Consumer Packaged Goods Cosmetics Dental Care

Description

JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture products under the Dr. Gold and Aquawhite brands. It also provides contract manufacturing services for oral care products of other brands; and operates retail stores at airports. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1996 and is based in New Delhi, India.

Key trends

Past 5 years